A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults

By Alice Minhinnick et al.
Published: April 12, 2016, 9:23 p.m.· Tags: Vaccines

Read More →